Spark! Warning about Roche!

Quote

anonymous

Guest
Are you guys at Spark ready to be Roche-ified? Say good bye to your entrepreneurial spirit and say hello to Swiss process and back stabbing. You will love it. Just ask Genentech.......
 






Does Roche really leave companies alone? Here at Spark's they promised to leave us alone, so far they have followed through on their pledge to leave us alone. We haven't fully been assimilated into the Roche culture, we still are operating as a stand alone unit.
 






enjoy it while it lasts. once you get your approvals for srp-9001 in tier 1 markets, you'll be hooked up to the Borg. and the Swiss Borg is even more mundane and collective than the one in Star Trek.

anonymous said:
Does Roche really leave companies alone? Here at Spark's they promised to leave us alone, so far they have followed through on their pledge to leave us alone. We haven't fully been assimilated into the Roche culture, we still are operating as a stand alone unit.
Click to expand...
 


















anonymous said:
Does Roche really leave companies alone? Here at Spark's they promised to leave us alone, so far they have followed through on their pledge to leave us alone. We haven't fully been assimilated into the Roche culture, we still are operating as a stand alone unit.
Click to expand...

With Genentech, it took a while for Roche to complete the Borg takeover. A system here, a logo there, removal of some benefits that "don't align". And soon enough you are speaking vith zee Germon akzent.
 






Looks like leaving Spark alone wasn't really a good idea. The Spark pipeline was hyped up by its Exec’s and most if not all if it has been shelved by Roche. Spark has nothing but an old Gene Therapy for an indication that has dried up, they have a $600 million annual burn rate, and spent $800 million on a manufacturing plant in the middle of a city and are now trying to get Sereptas product in there to save them. Bye bye Spark.
 






anonymous said:
Looks like leaving Spark alone wasn't really a good idea. The Spark pipeline was hyped up by its Exec’s and most if not all if it has been shelved by Roche. Spark has nothing but an old Gene Therapy for an indication that has dried up, they have a $600 million annual burn rate, and spent $800 million on a manufacturing plant in the middle of a city and are now trying to get Sereptas product in there to save them. Bye bye Spark.
Click to expand...
Classic pump n' dump by the sparkers.

There's a sucker born everyday.
 






anonymous said:
Looks like leaving Spark alone wasn't really a good idea. The Spark pipeline was hyped up by its Exec’s and most if not all if it has been shelved by Roche. Spark has nothing but an old Gene Therapy for an indication that has dried up, they have a $600 million annual burn rate, and spent $800 million on a manufacturing plant in the middle of a city and are now trying to get Sereptas product in there to save them. Bye bye Spark.
Click to expand...
So at this point Roche has just about doubled down on Spark since its $4.3 billion purchase, prob spent another $4-5 billion in carrying costs, and has nothing to show for it except a building that ate up $800 million in cash!! If I recall the press release correctly, Roche doesn’t own the new building or the property either. Is anyone on the Roche Board addressing this???
 


















Top Bottom
Back
Quote